Marty, M <br/><br/>
A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  1990 
 - S28-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Chlorpromazine--therapeutic use<br/>Dexamethasone--therapeutic use<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Granisetron<br/>Humans<br/>Indazoles--therapeutic use<br/>Male<br/>Middle Aged<br/>Serotonin Antagonists--therapeutic use<br/>Time Factors<br/>Vomiting--chemically induced